Introduction
============

Keratoconus is the most common primary corneal ectasia.[@b1-opth-12-147] It is a bilateral and asymmetric corneal degeneration characterized by localized corneal thinning which leads to protrusion of the thinned cornea.[@b2-opth-12-147]--[@b5-opth-12-147] Intrastromal corneal ring segment (ICRS) can be used in the treatment of keratoconus as it acts by an arc-shortening effect, flattens the center of the cornea, and provides a biomechanical support for the thin ectatic cornea.[@b6-opth-12-147] It aims to defer the need for corneal transplantation and restore contact lens tolerance (by making their astigmatism more regular).[@b6-opth-12-147]

The corneal collagen cross-linking (CXL) by the photo-sensitizer riboflavin and ultraviolet A (UVA) light is the main treatment that changes the intrinsic biomechanical properties of corneal collagen and was first introduced by Wollensak.[@b7-opth-12-147] It creates additional chemical bonds inside the corneal stroma by means of a photo-polymerization in the anterior stroma.[@b7-opth-12-147] The placement of riboflavin in the stroma can be done by different methods with or without epithelial removal, or using the tunnel created by a femtosecond laser for ICRS placement.[@b8-opth-12-147]--[@b10-opth-12-147]

ICRS implantation can be combined with CXL in progressive cases of keratoconus, and their effect is potentially synergistic. The ideal sequence and timing of the two procedures are still controversial.[@b11-opth-12-147]--[@b13-opth-12-147] In our study, we compared the effect of simultaneous ICRS implantation and CXL versus combined ICRS implantation and CXL.

Patients and methods
====================

This was a prospective, randomized, interventional comparative clinical cohort study that included 20 eyes of 12 patients with moderate-to-severe keratoconus. Diagnosis was based on slit-lamp examination and corneal topography. Keratoconus cases were classified according to the Amsler--Krumeich grading system.

Our study was approved by the ethical committee of ophthalmology department, Cairo University, and it followed the principles of the Declaration of Helsinki. In adherence with our institutional guidelines, all patients provided a written informed consent.

All eyes included in the study had keratoconus grades II--III with contact lens intolerance and corneal thickness at the thinnest point of at least 400 µm with clear cornea. We excluded pregnant or breast-feeding patients and those with the following diagnoses: grade IV keratoconus; hydrops; corneal opacity; severe atopy; collagen, vascular, autoimmune, or other ocular or systemic disease.

The patients were randomly divided into two groups (based on a selection card chosen by the patient). Group A underwent simultaneous ICRS implantation with intratunnel cross-linking. Group B underwent simultaneous ICRS implantation with epithelium-off (epi-off) cross-linking. In all cases, the following examinations were performed before surgery and at 6 months postoperatively: uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction, slit-lamp biomicroscopy, indirect ophthalmoscopy, intraocular pressure (IOP) by tonometry, Scheimpflug imaging with a Pentacam device (Oculus Optikgeräte, GmbH), and corneal hysteresis (CH) by Ocular Response Analyzer (Reichert Ophthalmic Instruments, Depew, NY, USA).

Surgical technique
------------------

The procedure was done under topical anesthesia using benoxinate hydrochloride 0.4% eye drops (Benox; Eipico Inc., Cairo, Egypt). This was followed by application of topical moxifloxacin hydrochloride 0.5% (Vigamox; Alcon Surgical, Fort Worth, TX, USA) eye drops as a prophylaxis against infection.

Tunnel formation
----------------

The creation of the intrastromal pocket for Kera ring implantation was performed by means of the 200 kHz femtosecond technology FS200 (Alcon Surgical) in all cases. A vacuum ring was fixated to the eye after a tunnel is created under high IOP.

Kera ring implantation
----------------------

According to specific nomogram, the Kera ring (Mediphacos, Belo Horizonte, Brazil) was selected, with 5 mm diameter (4.4 mm internal diameter and 5.6 mm external diameter), variable thickness (150--300 µm), and four arc segments (90°, 120°, 160°, and 210°). It was inserted into this corneal tunnel. In the intratunnel CXL group, injection of the isoosmolar riboflavin 0.1% solution in 20% dextran (VibeX; Avedro Inc., Waltham, MS, USA) in the pocket was done before insertion of the ring, and then the cornea was exposed to UVA radiation of 370 nm, at 18 mW/cm^2^ for 5 min. In the epi-off CXL group, the epithelium in the central 8--9 mm was removed by a blade, and then isoosmolar riboflavin 0.1% solution in 20% dextran (VibeX, Avedro Inc.) was applied for 5 min and exposed to UVA radiation of 370 nm, at 18 mW/cm^2^ for 5 min. Then, a soft bandage contact lens was applied that was removed on the first day in Group A and after epithelial continuity in Group B between 5 and 7 days.

Postoperatively, topical antibiotics and nonsteroidal anti-inflammatory drugs were prescribed. Topical steroids were initiated after complete healing of the epithelium in Group B and from the start in Group A.

Postoperative assessment
------------------------

Postoperative visits were scheduled for the first postoperative day, the first week, first month, and 6 months after surgery. On the first postoperative day, slit-lamp examination was performed to ensure the Kera ring position, corneal haze, and integrity. The patients with epi-off cross-linking were followed up until complete epithelization. Six months after the surgery, full ophthalmological examination, corneal topography, and ORA were performed.

Statistical analysis
--------------------

Statistical analyses were done using Microsoft Excel 2010 and SPSS software version 20.0 for Windows. Data were presented in terms of parametric and nonparametric data using Kolmogrov--Smirnov test. All data showed normal distribution, and paired *t*-test was used for statistical analysis to compare data before and after each treatment. Independent *t*-test was used to compare data of two groups. All values are given as mean ± SD. All tests were two-tailed and considered significant at *P*\<0.05 and highly significant at *P*\<0.01.

Results
=======

Study population
----------------

A total of 20 eyes of 12 patients were classified into two groups. Group A underwent simultaneous ICRS implantation with intratunnel cross-linking and included 10 eyes of six patients (two males and four females) with a mean age of 24.4 (±4.85 years), while Group B underwent ICRS implantation with epi-off cross-linking and included 10 eyes of six patients (four males and two females) with a mean age of 23 (±5.5) years.

Group A
-------

[Table 1](#t1-opth-12-147){ref-type="table"} shows the comparison between preoperative and postoperative results. As shown, there was a statistically significant improvement in the logMAR UDVA (mean change was 0.38) and logMAR CDVA (mean change was 0.1) (*P*\<0.05). There was also a statistically significant decrease in the manifest sphere and cylinder (mean change was −2.5 D and −1.72 D, respectively) (*P*\<0.05). We also found a decrease in the mean *K* and *K*~max~ readings (mean change was 3.69 D and −3.92 D, respectively). There was no statistically significant increase in the corneal thickness at the pachy apex and the thinnest location. There was a statistically significant decrease in the CH (mean change was −0.44 mmhg) (*P*\<0.05), but the change in the corneal resistance factor (CRF) was found to be statistically nonsignificant (0.18 mmhg, *P*=0.892). [Figure 1A and B](#f1-opth-12-147){ref-type="fig"} shows an example of Pentacam of one of the patients of this group.

Group B
-------

[Table 2](#t2-opth-12-147){ref-type="table"} shows a comparison of pre- and postoperative results in Group B. There was an improvement in the UDVA (0.26 logMAR) and best-corrected visual acuity (BCVA) (0.21 logMAR) (*P*\<0.05). There was also a statistically significant decrease in the manifest cylinder (−1.85 D) (*P*\<0.05), but the change in the manifest sphere was not significant (−0.45 D, *P*=0.66). There was a statistically significant decrease in the mean *K* and *K*~max~ readings (−2.53 and −4.038 D). There was no statistically significant increase in the corneal thickness at the pachy apex and the thinnest location. There was a decrease in the CH by ORA at 6 months postoperatively (0.46 mmhg) (*P*\<0.05) and an increase in CRF that was statistically nonsignificant (0.22 mmhg, *P*=0.401). [Figure 2A and B](#f2-opth-12-147){ref-type="fig"} shows the Pentacam of patients in Group B before and after treatment.

On comparing both groups, we found a statistically nonsignificant difference between them in all parameters tested ([Figures 3](#f3-opth-12-147){ref-type="fig"} and [4](#f4-opth-12-147){ref-type="fig"}). [Table 3](#t3-opth-12-147){ref-type="table"} shows the mean difference between the groups in all variables tested with corresponding level of significance. As shown, there was no statistically significant difference between the groups in all tested variables.

Discussion
==========

The combination of ICRS implantation and CXL has a synergistic effect in improving the visual acuity and slowing the progression of keratoconus. The ideal sequence and timing of these procedures are still controversial.[@b11-opth-12-147]--[@b13-opth-12-147] Some surgeons prefer rings inserted first so that the segments can reshape the cornea without restriction.[@b12-opth-12-147] Others perform CXL first to further flatten the cornea and to enhance corneal biomechanics and prevent progression.[@b14-opth-12-147]

Our study described the combination of Kera ring implantation with CXL as a safe and effective treatment option in patients with keratoconus and contact lens intolerance.

In our study, the mean UDVA improved significantly at 6 months postoperatively. Compared with the studies published on Kera ICRS, mean UDVA in our patients increased with more Snellen lines after combined treatment than after implantation of Kera ring segments alone.[@b15-opth-12-147],[@b16-opth-12-147] Our results are in line with the study by Coskunseven et al that used combined ICRS implantation with CXL starting with either the CXL or the rings.[@b16-opth-12-147] However, in their study, the improvement was more in ICRS implantation group followed by CXL group after 7 months than the reverse sequence. Liu et al in their study showed that combined ICRS implantation and immediate CXL will improve the UDVA, BCVA, and spherical and cylindrical error but with no statistical difference in comparison to ICRS only or CXL followed by ICRS implantation.[@b17-opth-12-147]

In comparison with Kilic et al's study on 131 eyes with a mean follow-up of about 7 months, the mean improvement in logMAR UDVA was 0.26±0.16 (in our study, it was 0.38±0.25) and logMAR BCVA was 0.24±0.16 (in our study, it was 0.1±0.15), and the mean manifest cylinder improved from −3.89 (±1.97) to −2.27 (±2.18) D. In our study, the cylinder decreased from −4.975 (±1.64) to −3.25 (±1.3) D.[@b10-opth-12-147]

El-Raggal in his prospective study divided the patients into two groups. Group 1 included nine eyes that underwent Kera rings insertion followed by CXL 6 months later, and Group 2 included seven eyes that underwent both the procedures simultaneously. The study showed that there was a statistically significant improvement in the final UDVA and BCVA, and decrease in spherical, cylindrical, and the mean keratometric reading from the preoperative values in the two groups. However, there was a statistically significant difference between the groups regarding the mean keratometric reduction with a greater reduction in Group 2 than in Group 1 (*P*=0.046).[@b11-opth-12-147]

Alió et al in their study divided 27 patients into a classic group who were subjected to CXL with epithelial debridement with ICRS implantation (16 eyes) and a second group where patients were subjected to CXL with an intrastromal pocket with ICRS implantation (11 eyes).[@b12-opth-12-147] There was no significant difference between the patients of the two groups in terms of visual acuity, refraction, aberrometry, and pachymetry, which is in line with our results.

CH and CRF reflect the biomechanical properties of the eye, and they are lower in keratoconic eyes than normal.[@b18-opth-12-147] There was a decrease in the CH after treatment in both groups which is in line with the results of Pinero et al, although in their study only ICRS implantation was used as treatment.[@b19-opth-12-147] However, Barbara et al detected no significant difference after combined treatment with Intacs SK and CXL.[@b20-opth-12-147] Dauwe et al detected that there was no significant change in the viscoelastic properties after ICRS implantation.[@b21-opth-12-147] In our study, we found a statistically significant decrease in CH and a statistically nonsignificant increase in CRF.

Conclusion
==========

The improvement in the UDVA, CDVA, manifest refraction, and keratometric values in our study may suggest that a simultaneous treatment might give better results than a sequential treatment, but larger sample sizes and longer follow-up are needed to validate these results. The nonsignificant difference between the groups widens the horizon of use of intratunnel CXL as a substitute of epi-off CXL when rapid visual recovery is needed or fear of epithelial defect is present. When we combined ICRS implantation with an intratunnel riboflavin injection, we obtained direct riboflavin penetration into the stroma without removing the epithelium. To our mind, this is the first randomized study to compare both techniques; however, a larger sample size and longer follow-up are recommended.
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![Pentacam (**A**) before and (**B**) after treatment (patient in Group A).](opth-12-147Fig1){#f1-opth-12-147}

![Pentacam (**A**) before and (**B**) after treatment (patient in Group B).](opth-12-147Fig2){#f2-opth-12-147}

![Mean difference in cylinder pre- and posttreatment of the two groups. The difference in the cylindrical error was 0.25 with a *P*-value of 0.773.\
**Abbreviations:** epi-off, epithelium-off; CXL, collagen cross-linking.](opth-12-147Fig3){#f3-opth-12-147}

![Mean difference in *K*~m~ pre- and posttreatment of the two groups. The difference in *K*~m~ was 1.39 with a *P*-value of 0.312.\
**Abbreviations:** epi-off, epithelium-off; CXL, collagen cross-linking.](opth-12-147Fig4){#f4-opth-12-147}

###### 

Pre- and postoperative changes following ICRS implantation with intratunnel CXL

  Parameters   Preoperative   Postoperative   Mean change (±SD)   *P*-value
  ------------ -------------- --------------- ------------------- ---------------------------------------------------
  *K*~m~       53.03          49.44           −3.69 (±3.06)       0.004[\*](#tfn1-opth-12-147){ref-type="table-fn"}
  *K*~max~     65.19          61.27           −3.92 (±5.5)        0.05[\*](#tfn1-opth-12-147){ref-type="table-fn"}
  Pachy apex   431.5          432.4           0.9 (13.8)          0.842
  Thinnest     418.9          422.4           3.5 (19.6)          0.587
  Sphere       5.075          2.575           −2.5 (2.35)         0.008[\*](#tfn1-opth-12-147){ref-type="table-fn"}
  Cylinder     4.975          3.25            −1.725 (±1.6)       0.009[\*](#tfn1-opth-12-147){ref-type="table-fn"}
  CRF          5.8            5.818           0.18 (0.406)        0.892

**Note:**

Statistically significant values.

**Abbreviations:** ICRS, intrastromal corneal ring segment; CXL, collagen cross-linking; CRF, corneal resistance factor.

###### 

Pre- and postoperative changes following ICRS with epi-off CXL

  Parameters   Preoperative   Postoperative   Mean change (±SD)   *P*-value
  ------------ -------------- --------------- ------------------- ---------------------------------------------------
  *K*~m~       52.543         50.348          −2.535 (1.8)        0.002[\*](#tfn3-opth-12-147){ref-type="table-fn"}
  *K*~max~     64.05          60.54           −4.038 (3.6)        0.006[\*](#tfn3-opth-12-147){ref-type="table-fn"}
  Pachy apex   439.5          446.7           13.2 (26.1)         0.145
  Thinnest     426            433.3           13.7 (25.8)         0.128
  UDVA         1.14           0.79            −0.26 (0.18)        0.002[\*](#tfn3-opth-12-147){ref-type="table-fn"}
  CDVA         0.59           0.35            −0.21 (0.213)       0.012[\*](#tfn3-opth-12-147){ref-type="table-fn"}
  Sphere       3.3            2.875           −0.45 (3.12)        0.66
  Cylinder     4.175          2.7             −1.85 (2.07)        0.002[\*](#tfn3-opth-12-147){ref-type="table-fn"}
  CH           6.89           6.56            −0.46 (0.36)        0.003[\*](#tfn3-opth-12-147){ref-type="table-fn"}
  CRF          5.52           5.85            0.22 (0.788)        0.401

**Note:**

Statistically significant values.

**Abbreviations:** ICRS, intrastromal corneal ring segment; epi-off, epithelium-off; CXL, collagen cross-linking; UDVA, uncorrected visual acuity; CDVA, corrected distance visual acuity; CH, corneal hysteresis; CRF, corneal resistance factor.

###### 

Comparison between the results of epi-off CXL and intratunnel CXL and their significance

               Mean difference between two groups   *P*-value
  ------------ ------------------------------------ -----------
  *K*~m~       1.39                                 0.312
  *K*~max~     0.412                                0.857
  Pachy apex   6.3                                  0.620
  Thinnest     3.8                                  0.780
  UDVA         0.03                                 0.798
  CDVA         −0.14                                0.126
  Sphere       2.07                                 0.111
  Cylinder     0.25                                 0.773
  CH           0.11                                 0.633
  CRF          0.31                                 0.313

**Abbreviations:** Epi-off, epithelium-off; CXL, collagen cross-linking; UDVA, uncorrected visual acuity; CDVA, corrected distance visual acuity; CH, corneal hysteresis; CRF, corneal resistance factor.
